- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Lifevantage Corp
+ Add to WatchlistLFVN:US
2.2500 USD 0.0200 0.88%As of 17:20:00 ET on 06/19/2013.
Snapshot for Lifevantage Corp (LFVN)
| Open: | 2.2800 | Day's Range: | 2.2200 - 2.3000 | Volume: | 389,120 |
|---|---|---|---|---|---|
| Previous Close: | 2.2700 | 52wk Range: | 1.6000 - 3.8500 | 1-Yr Rtn: | -22.95% |
Key Statistics for LFVN
| Current P/E Ratio (ttm) | 17.3077 |
|---|---|
| Estimated P/E(06/2013) | 25.0000 |
| Relative P/E vs. SPX | 1.0696 |
| Earnings Per Share (USD) (ttm) | 0.1300 |
| Est. EPS (USD) (06/2013) | 0.0900 |
| Est. PEG Ratio | 2.0833 |
| Market Cap (M USD) | 255.43 |
| Shares Outstanding (M) | 113.52 |
| 30 Day Average Volume | 537,444 |
| Price/Book (mrq) | 7.3240 |
| Price/Sale (ttm) | 1.2486 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/10/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for LFVN
Company Profile & Key Executives for LFVN
Lifevantage Corporation is a health and nutrition company that develops dietary supplements. The Company's product is intended to combat oxidative stress to the human body by producing superoxide dismustase (SOD) and catalase (CAT).
| Douglas C Robinson "Doug"President/CEO | David ColbertChief Financial Officer |
| Joe M McCordChief Scientific Officer | Robert UrbanChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
LFVN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page